Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China flag China · Delayed Price · Currency is CNY
14.05
+0.06 (0.43%)
Jun 9, 2026, 3:00 PM CST

SHA:600535 Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, SHA:600535 stock has a consensus rating of "Buy" and an average price target of ¥17.18. The average 1-year stock price forecast is 22.28% higher than the current stock price, while the lowest is ¥14.00 (-0.36%) and the highest is ¥18.70 (+33.10%).

Price Target: ¥17.18 (+22.28%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price¥14.00¥17.18¥18.00¥18.70
Change-0.36%+22.28%+28.11%+33.10%

Analyst Ratings

The average analyst rating for SHA:600535 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy333222
Buy222222
Hold211111
Sell000000
Strong Sell000000
Total766555

Financial Forecast

Revenue This Year
9.00B
from 8.24B
Increased by 9.21%
Revenue Next Year
9.87B
from 9.00B
Increased by 9.72%
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
7.95B8.64B8.67B8.50B8.24B9.00B
Revenue Growth
-41.43%8.62%0.42%-2.03%-3.08%9.21%
Gross Profit
5.27B5.49B5.79B5.69B5.49B6.16B
Gross Margin
66.27%63.56%66.74%66.94%66.70%68.43%
Operating Income
1.24B1.34B1.44B1.44B1.38B1.57B
Net Income
2.36B-264.24M1.07B955.59M1.10B1.33B
Dividend / Share
0.330.330.330.530.310.40
Dividend Growth
---60.61%-41.51%29.60%
Free Cash Flow
2.53B1.52B1.35B968.19M840.85M1.13B
No. Analysts
-----5
Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High9.1B
Avg9.0B
Low8.7B

Revenue Growth

Revenue Growth202620272028
High
10.7%
Avg
9.2%
Low
5.9%

EPS Forecast

EPS202620272028
High-
Avg-
Low-

EPS Growth

EPS Growth20272028
High-
Avg-
Low-